Capital World Investors Zai Lab LTD Transaction History
Capital World Investors
- $625 Billion
- Q3 2024
A detailed history of Capital World Investors transactions in Zai Lab LTD stock. As of the latest transaction made, Capital World Investors holds 6,435,383 shares of ZLAB stock, worth $172 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,435,383
Previous 5,307,939
21.24%
Holding current value
$172 Million
Previous $92 Million
68.88%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding ZLAB
# of Institutions
121Shares Held
46.7MCall Options Held
223KPut Options Held
588K-
Janus Henderson Group PLC London, X08.76MShares$234 Million0.11% of portfolio
-
Wellington Management Group LLP Boston, MA8.44MShares$225 Million0.04% of portfolio
-
Viking Global Investors LP1.95MShares$52.1 Million0.18% of portfolio
-
Bamco Inc New York, NY1.91MShares$50.9 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.81MShares$48.2 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.62B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...